^
BIOMARKER:
B2M-H
i
Other names: B2M, Beta-2-microglobulin
Entrez ID:
›
B2M-H
|
CLL
|
B2M-H
|
CLL
|
ibrutinib Resistant: C3 – Early Trials
|
ibrutinib Resistant: C3 – Early Trials
|
B2M-H
|
CLL
|
B2M-H
|
CLL
|
venetoclax + ibrutinib Sensitive: C3 – Early Trials
|
venetoclax + ibrutinib Sensitive: C3 – Early Trials
|
B2M-H
|
Multiple Myeloma
|
B2M-H
|
Multiple Myeloma
|
Immunomodulator Resistant: C3 – Early Trials
|
Immunomodulator Resistant: C3 – Early Trials
|
B2M-H
|
Multiple Myeloma
|
B2M-H
|
Multiple Myeloma
|
Proteasome inhibitor + Immunomodulator Resistant: C3 – Early Trials
|
Proteasome inhibitor + Immunomodulator Resistant: C3 – Early Trials
|
B2M-H
|
Multiple Myeloma
|
B2M-H
|
Multiple Myeloma
|
Proteasome inhibitor Resistant: C3 – Early Trials
|
Proteasome inhibitor Resistant: C3 – Early Trials
|
